Sangani Hospitals first-half profit reaches Rs 2.20 crore
Key highlights
- Sangani Hospitals reported consolidated total revenue of Rs 25.90 crore for the half year ended September 30, 2026, compared with Rs 20.69 crore a year earlier.
- Sangani Hospitals reported Rs 2.20 crore of consolidated profit after minority interest, compared with Rs 1.00 crore in the September 2025 half year.
- Sadbhavna became a Sangani Hospitals subsidiary on October 17, 2025 after Sangani Hospitals acquired 55% of its paid-up equity share capital.
- Sangani Hospitals’ consolidated cash and cash equivalents increased to Rs 16.27 crore at September 30, 2026 from Rs 11.84 crore at March 31, 2026.
powered by IRIS

Sangani Hospitals Limited reported consolidated profit after minority interest of Rs 2.20 crore for the half year ended September 30, 2026, compared with Rs 1.00 crore a year earlier, while total revenue reached Rs 25.90 crore. The company said the comparison is not comparable because Sadbhavna was consolidated only after its October 2025 acquisition.
Know Sangani Hospitals inside out
Results, valuation, peers and who's buying, in one view.
What did Sangani Hospitals report for the first half?
Sangani Hospitals reported revenue from operations of Rs 25.28 crore for the half year ended September 30, 2026, compared with Rs 20.47 crore in the half year ended September 30, 2025. Other income rose to Rs 62.09 lakh from Rs 21.59 lakh, taking total revenue to Rs 25.90 crore from Rs 20.69 crore.
Profit before tax was Rs 3.77 crore in the September 2026 half year, compared with Rs 1.30 crore a year earlier. Total tax expense increased to Rs 94.88 lakh from Rs 29.00 lakh, leaving profit for the period of Rs 2.82 crore, compared with Rs 1.01 crore in the September 2025 half year.
Minority interest was Rs 62.37 lakh in the latest half year, and the consolidated statement reported profit after minority interest of Rs 2.20 crore, against Rs 1.00 crore a year earlier. The statement also reported basic and diluted earnings per share, or EPS, of Rs 1.59, compared with Rs 0.73; the equity-share face value is Rs 10.
Sangani Hospitals’ audit committee reviewed and recommended the unaudited results on November 14, 2026, when the board approved them. R G G R & Associates LLP issued a limited review report, which said nothing had come to its attention to indicate that the consolidated statement contained a material misstatement.
Why are Sangani Hospitals’ year-on-year results not comparable?
Sangani Hospitals said its September 2026 consolidated results are not directly comparable with the September 2025 figures because the consolidation group changed. The latest period includes Sangani Hospitals, Ankur Distributors and Sadbhavna Hospital and Medical Research Centre Private Limited, while the September 2025 comparative included only Sangani Hospitals and Ankur Distributors.
Sadbhavna became a subsidiary on October 17, 2025 after Sangani Hospitals acquired 55% of its paid-up equity share capital. During the year ended March 31, 2026, Sangani Hospitals invested Rs 18.81 crore in Sadbhavna; the March 2026 annual consolidated results included Sadbhavna only from October 17, 2025 onwards.
The company reported profit for the period of Rs 2.82 crore before minority interest for the September 2026 half year and Rs 2.20 crore after the Rs 62.37 lakh minority-interest amount. Non-controlling interest on the consolidated balance sheet was Rs 10.21 crore at September 30, 2026, compared with Rs 9.58 crore at March 31, 2026.
Sangani Hospitals identifies healthcare-related services as its sole reportable segment under Accounting Standard 17, or AS 17, and therefore did not provide separate revenue or profit figures for hospitals, distribution or Sadbhavna. The results were prepared under Accounting Standard 25, or AS 25, for interim financial reporting, while the company said Indian Accounting Standards do not apply to it.
Got a follow-up? Ask IRIS
How did Sangani Hospitals’ costs and balance sheet change?
Sangani Hospitals’ consolidated total expenses rose to Rs 22.13 crore in the half year ended September 30, 2026 from Rs 19.39 crore a year earlier. Purchases of stock in trade declined to Rs 7.63 crore from Rs 13.11 crore, while employee benefit expenses increased to Rs 4.01 crore from Rs 2.05 crore and other expenses rose to Rs 10.28 crore from Rs 3.82 crore.
Depreciation and amortisation increased to Rs 59.20 lakh from Rs 33.75 lakh, while finance costs were Rs 2.27 lakh in the September 2026 half year; the September 2025 column carried no finance-cost figure. Changes in inventories were a Rs 39.92 lakh credit in the latest period, compared with a Rs 7.14 lakh expense a year earlier.
Total consolidated assets were Rs 103.11 crore at September 30, 2026, down from Rs 113.64 crore at March 31, 2026. Trade receivables declined by Rs 13.72 crore to Rs 47.83 crore, while cash and cash equivalents rose by Rs 4.43 crore to Rs 16.27 crore over the same six-month balance-sheet comparison.
Consolidated shareholders’ funds increased to Rs 43.18 crore at September 30 from Rs 40.98 crore at March 31. Long-term borrowings rose to Rs 2.76 crore from Rs 1.28 crore, short-term borrowings fell from Rs 50.00 lakh to nil, and trade payables declined to Rs 42.22 crore from Rs 54.62 crore.
What does Sangani Hospitals’ cash flow show?
Sangani Hospitals generated net cash from operating activities of Rs 1.96 crore in the half year ended September 30, 2026. Cash generated from operations before direct taxes was Rs 2.78 crore, while direct taxes paid were Rs 81.94 lakh.
The cash-flow statement recorded a Rs 13.72 crore decrease in trade receivables, partly offset by a Rs 12.40 crore decrease in trade payables and a Rs 2.03 crore decrease in other current liabilities. Operating profit before working-capital changes was Rs 4.10 crore, including Rs 59.20 lakh of depreciation and a Rs 28.61 lakh interest-income adjustment.
Investing activities generated Rs 3.51 crore during the half year, including Rs 3.50 crore from current investments and Rs 50.00 lakh from other non-current investments. These inflows exceeded Rs 97.24 lakh spent on fixed assets, while capital work in progress declined by Rs 20.09 lakh.
Financing activities used Rs 1.04 crore, reflecting Rs 2.50 crore invested in or placed in bank deposits and Rs 1.49 crore of additional long-term borrowings. Net cash and cash equivalents increased by Rs 4.44 crore from Rs 11.84 crore at March 31, 2026 to Rs 16.27 crore at September 30, 2026.
Conclusion
Sangani Hospitals delivered higher reported consolidated revenue and profit in the half year ended September 30, 2026, with total revenue of Rs 25.90 crore and profit after minority interest of Rs 2.20 crore. The increase over the September 2025 half year, when revenue was Rs 20.69 crore and reported profit was Rs 1.00 crore, spans a changed reporting group following Sadbhavna’s consolidation.
The unresolved issue for subsequent comparisons is the effect of Sadbhavna, which was absent from the September 2025 comparative but was a subsidiary from October 17, 2025. Readers can also watch movement in the September 30 balance-sheet amounts of Rs 47.83 crore in trade receivables, Rs 42.22 crore in trade payables and Rs 16.27 crore in cash and cash equivalents.


